Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Systematic review of outcomes and endpoints in acute migraine clinical trials.

PMID: 33611818 ·

C, a, r, r, i, e, , R, , H, o, u, t, s, ;, , J, a, m, e, s, , S, , M, c, G, i, n, l, e, y, ;, , T, r, a, c, y, , K, , N, i, s, h, i, d, a, ;, , D, a, w, n, , C, , B, u, s, e, ;, , R, , J, , W, i, r, t, h, ;, , D, a, v, i, d, , W, , D, o, d, i, c, k, ;, , P, e, t, e, r, , J, , G, o, a, d, s, b, y, ;, , R, i, c, h, a, r, d, , B, , L, i, p, t, o, n

RevistaHeadache
Año
PMID33611818

Resumen

To review the acute migraine clinical trial literature and provide a summary of the endpoints and outcomes used in such trials. A systematic literature review, following a prespecified (but unregistered) protocol developed to adhere to recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, was conducted to understand endpoints and outcomes used in acute migraine clinical trials. Predefined terms were searched in PubMed to locate clinical trials assessing acute

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑